About
Sebia USA is the American subsidiary of Sebia, a leader in In Vitro Diagnostics (IVD) that specializes in clinical protein electrophoresis equipment and reagents. Founded in 1967 and headquartered near Paris, France, Sebia focuses on advanced diagnostic tools for screening and monitoring diseases, particularly in oncology, diabetes, hemoglobinopathy, autoimmune and infectious diseases, and rare pathologies. The company’s core technology is Capillary Electrophoresis (CE), which accurately separates proteins and other molecules to aid in diagnosing complex biological conditions. Sebia USA offers a range of products, including automated analyzers, consumables for protein analysis, and specialized tests like the A1c Assay for diabetes management. Their Sebia Lean Service enhances laboratory performance with tailored solutions and expert support. With a strong commitment to research and development, Sebia continuously innovates to expand its diagnostic capabilities. Operating in over 120 countries, Sebia USA serves clinical laboratories, hospitals, and research institutions, providing essential diagnostic solutions and support to improve patient care worldwide.
Keywords
Company Information
-
Employees 93
-
Founded 1997
-
Annual Revenue $10000000
Location
1705 Corporate Dr, Norcross, Georgia, United States, 30093
